Results Imminent From Sweden’s Pilot Of Novel Antibiotic Reimbursement Model
Executive Summary
If successful, a new Swedish model for reimbursing antibiotics that involves guaranteed minimum annual revenues for companies, could be tested on other kinds of products.
You may also be interested in...
England: Shionogi And Pfizer Ink ‘World First’ Payment Model Deal For Antibiotics
Shionogi and Pfizer have formally agreed to a scheme that offers companies a new and sustainable payment model for innovating in antibiotics.
Roche Wants EU Pharma Legislative Revision To ‘Dare Something New’
New, more flexible regulatory approaches will be needed to deal with the integrated therapies coming through company pipelines, and the European Medicines Agency should play a “key orchestrating role” in smoothing the way, says Sabine Atzor, Roche’s head of EU regulatory policies.
WHO’s Draft Pandemic Treaty Calls For More Regulatory Harmonization
Regulatory convergence and the sharing of dossiers, together with the timely and equitable sharing of pathogens, could help to speed up access to diagnostics, vaccines and medications in pandemic situations, according to the first draft of the World Health Organization’s proposed pandemic treaty.